BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29343543)

  • 1. An Autoimmune Disease-Associated Risk Variant in the
    Lou L; Bao W; Liu X; Song H; Wang Y; Zhang K; Gao W; Li H; Tu Z; Wang S
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population.
    Xu M; Gao W; Wu L; Liu X; Yu D; Shi X; Liu X; Wang Q; Fu X; Yu J; Xu B; Wang S
    Hum Immunol; 2019 Feb; 80(2):140-145. PubMed ID: 30529365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
    Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
    Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
    Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
    Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    Xu E; Cao H; Lin L; Liu H
    PLoS One; 2017; 12(4):e0176471. PubMed ID: 28448618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus.
    Wang S; Wen F; Tessneer KL; Gaffney PM
    Genes Immun; 2016 Apr; 17(3):165-70. PubMed ID: 26821284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population.
    Li N; Shi Y; Zhang P; Sang J; Li F; Deng H; Lv Y; Han Q; Liu Z
    Virol J; 2017 Aug; 14(1):148. PubMed ID: 28784141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
    He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
    Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
    PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
    Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
    Hoffjan S; Okur A; Epplen JT; Wieczorek S; Chan A; Akkad DA
    Int J Immunogenet; 2015 Apr; 42(2):106-10. PubMed ID: 25684197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
    Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
    J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.
    Gomes MT; Campos PC; Pereira Gde S; Bartholomeu DC; Splitter G; Oliveira SC
    J Leukoc Biol; 2016 May; 99(5):771-80. PubMed ID: 26578650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.